compounding tirzepatide fda confirms shortage is still over, gives compounders a grace period What happens if tirzepatide gets

This study suggests a molecular crosstalk between the E2F1/pRb and GLP1R signaling pathways that modulates insulin secretion and glucose homeostasis

How to use it

In todays fast-evolving healthcare landscape, few trends are reshaping care delivery as rapidly as telehealth and the rise of GLP-1based treatments for weight management and diabetes

Thats a good development for employers, clinicians, and the millions of people who need effective obesity treatment

Obesity remains a pressing public health concern, impacting millions of individuals worldwide and leading to severe health complications like diabetes, cardiovascular diseases, and even certain cancers (World Health Organization)

Merck had other China deals in the last few months (LaNova Medicines and Curon Biopharmaceutical), but all deals are either early-stage (ongoing Phase 1) or pre-clinical (Hansoh)